For those that care to know or pass the info on
to someone that actually has a reason to have
this test done So SOON...in the USA *ONLY*
Go to http://wwwwpinstitute.org and the link
for the Press Release in ON their Homepage.
WPI has finally sent out THIS
Press Release announcing this:
Viral Immune Pathology Diagnostics
Introduces New Test for XMRV Patients
and Clinicians
-Net proceeds from test dedicated
to further WPI research-
RENO, Nev.–The Whittemore Peterson Institute
(WPI) has recently published a research study
revealing the prevalence of XMRV in patients
with Myalgic Encephalomyelitis/Chronic
Fatigue Syndrome, ME/CFS or what has most
recently been called, X associated
neuro-immune disease, (XAND).
In response to an overwhelming request
for a diagnostic test for XMRV,
WPI has "temporarily agreed" to allow
Viral Immune Pathology Diagnostics
(VIP Dx) to begin offering the identical
tests that have been extensively
validated using the same technology
developed by Drs. Lombardi and Mikovits and
their colleagues as reported in Science.
VIP Dx is a small state certified laboratory
in Reno, Nevada that was formed in
response to the September 11, 2001 crisis
which resulted in the cessation of
blood sample shipments between the
United States and Europe. Faced with the loss
of important lab tests impacting patients with
neuro-immune diseases, the Whittemore
family made the decision to support the
lab in Reno.
"Our family made it possible for the lab to
not only continue delivering diagnostic tests
to doctors, but also help the WPI bring
cutting edge biomarkers of disease to this
field of medicine, such as the tests for XMRV,"
said Annette Whittemore, Founder and
President of WPI. "Tests conducted for
XMRV, and other tests that support
the diagnostic process in this field,
will support the continuation of vital
work at WPI through our donation
of all of our net proceeds."
XMRV test acceptance commenced at
VIP Dx this month. For more information
about the XMRV test kit,
visit http://www.vipdx.com.
Whittemore Peterson Institute
Thursday, November 5, 2009
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment